Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                34%
                                OVERLAP
BY WEIGHT
10
                                # OF OVERLAPPING
HOLDINGS
MEDX
                            28
                                HOLDINGS
                            
                                    36%
                                
                                ALSO IN PJP
                            PJP
                            29
                                HOLDINGS
                            
                                    34%
                                
                                ALSO IN MEDX
                            SECTOR DRIFT (MEDX minus PJP)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX  | 
                                Weight in PJP  | 
                                Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 15.5% | 5.4% | 5.4% | |
| ABBVIE INC | 9.0% | 5.3% | 5.3% | |
| JOHNSON & JOHNSON | 4.9% | 5.1% | 4.9% | |
| AMGEN INC | 3.8% | 4.9% | 3.8% | |
| PFIZER INC | 3.4% | 5.2% | 3.4% | |
MEDX Overweight Relative to PJP
                | ELI LILLY & CO | 10.1% | |
| NOVARTIS AG-ADR | 6.4% | |
| ALNYLAM PHARMACEUTICALS INC | 6.1% | |
| ASTRAZENECA PLC-SPONS ADR | 5.1% | |
| IONIS PHARMACEUTICALS, INC. | 5.0% | |
| ALKERMES PLC | 3.8% | |
| ABBVIE INC | 3.6% | |
| CRISPR THERAPEUTICS AG | 3.6% | |
| GLAXOSMITHKLINE PLC-SPON ADR | 2.8% | |
| GALECTIN THERAPEUTICS INC | 1.7% | 
MEDX Underweight Relative to PJP
                | ABBOTT LABORATORIES | -4.9% | |
| GILEAD SCIENCES INC | -4.7% | |
| UNITED THERAPEUTICS CORP | -3.8% | |
| TRAVERE THERAPEUTICS, INC. | -3.7% | |
| CORCEPT THERAPEUTICS INC | -3.3% | |
| LIGAND PHARMACEUTICALS-CL B | -2.9% | |
| JAZZ PHARMACEUTICALS PLC | -2.9% | |
| AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.9% | |
| TARSUS PHARMACEUTICALS, INC. | -2.9% | |
| SUPERNUS PHARMACEUTICALS INC | -2.8% |